All In Biotech

Free tool

FAERS Monitor: Kapspargo Sprinkle

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210428 or its brand name (Kapspargo Sprinkle, Metoprolol Succinate). Reports on generic versions are filed under their own applications.

Reports

64,013

Serious

40,110

63% of reports

Hospitalization

21,660

Death reported

5,990

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue4,958
  • diarrhoea4,077
  • dyspnoea3,874
  • nausea3,812
  • dizziness3,238
  • drug ineffective3,140
  • off label use3,106
  • headache2,969
  • death2,656
  • asthenia2,454
  • pain2,317
  • fall2,218
  • cough2,081
  • pneumonia1,971
  • vomiting1,908

Reports by year received

View as table
YearReports
2004586
2005535
2006678
20071,507
2008857
20091,212
2010935
20111,611
20121,916
2013567
20141,012
20151,828
20162,529
20173,265
20184,179
20194,262
20204,217
20213,973
20224,653
20235,082
20246,106
20257,085
20265,418

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,990,146 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
coughSignal2,0812.42.31,793
dyspnoeaSignal3,8742.32.22,767
fallSignal2,2182.22.11,460
astheniaSignal2,4542.22.11,530
dizzinessSignal3,2382.12.12,001
fatigueSignal4,9582.12.02,944
diarrhoeaSignal4,0772.12.02,349
pneumoniaSignal1,9712.01.91,003
nausea3,8121.61.5851
headache2,9691.61.5609
vomiting1,9081.31.3163
pain2,3171.21.2110
off label use3,1061.21.176
death2,6561.01.00
drug ineffective3,1400.80.8202

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.